At a glance
NorCal Cannabis Company is a vertically integrated California operator whose roots reach from a permitted San Francisco medical-delivery business to cultivation, manufacturing, distribution, retail and a house of consumer brands. Its public timeline begins in 2014, and its best-documented current consumer connection is lolo, a Santa Rosa flower and pre-roll brand.
Founded in San Francisco in 2014
NorCal says it formed in November 2014 with San Francisco’s first permitted medical cannabis delivery dispensary. Co-founders Jigar Patel and Douglas Cortina are identified in company material and independent business reporting. Their backgrounds combined finance, operations and cannabis-market experience during California’s transition from local medical rules to statewide licensing.
The company opened a Bryant Street cultivation site in July 2015, added a Mission District cultivation and manufacturing operation in February 2016, and established Santa Rosa cultivation in June 2016.
From medical cannabis to state licensing
The timeline shows retail development during 2017, state licenses secured in January 2018 and the first adult-use sale in February 2018. Those dates matter because “seed to sale” was built through separate licensed functions, not created as one undifferentiated brand.
NorCal publicly lists multiple California license identifiers, including C12-0000430-LIC. License status, premises and ownership can change, so current state and local databases remain the authority for any transaction or compliance decision.
Leadership and capital
Jigar Patel is presented by the company as co-founder and co-chief executive officer; its leadership page also names David Hofflich as co-CEO. A 2018 financing round reported by the North Bay Business Journal raised $27.4 million to expand Santa Rosa operations and identified Patel and Cortina as founders.
The company says Patel helped raise more than $100 million and grow revenue from $2 million to more than $70 million over three years. Those figures are company-reported historical claims, not current audited financials, and should be read with that limitation.
A vertically integrated platform
NorCal describes capabilities spanning cultivation, manufacturing, distribution, consumer brands, retail and business intelligence. This structure allows the company to participate at multiple points in California’s regulated supply chain and to support brands with shared infrastructure.
Older company pages also contain goals tied to 2022 and past “top three” positioning. Those statements describe prior ambitions or historical snapshots; they should not be presented as proof of current rank.
The original house of brands
In 2019, NorCal publicly unveiled a six-brand portfolio: 1Lyfe, Big Al’s Exotics, lolo, Occidental Hills, Panacea and Pass It Forward. Each was positioned for a distinct audience or product story inside the company’s broader platform.
That announcement also cited roughly 1,000 employees, 2,000 daily deliveries and a $100 million annualized revenue run rate. These are dated 2019 company figures—not a current headcount, delivery volume or valuation.
lolo and Santa Rosa cultivation
lolo says it was founded in Santa Rosa in 2018 and operates across 40 rooms and 1,600 lights, producing indoor flower and legacy genetics. Its public catalog centers on flower and pre-rolls, with C12-0000430-LIC displayed on the site.
Headset’s July 2026 California snapshot ranked lolo number 33 in flower, tracked it in 326 dispensaries and reported a mix of 77.43 percent flower and 22.57 percent pre-rolls. Those figures are a dated third-party measurement, not a permanent market position.
Pass It Forward
Pass It Forward was introduced with a social-impact model: directing proceeds and grants toward people and communities harmed by the war on drugs. That mission was part of the 2019 portfolio launch and gives the brand a role beyond product segmentation.
Impact claims should still be evaluated through current grant reporting and active programs. The launch announcement establishes intent and structure, but not the present size of distributions.
What changed as the company grew
NorCal’s chronology captures a broader California story: a medical delivery operator added cultivation and manufacturing, crossed into state adult-use licensing, raised institutional capital and assembled consumer brands. The business became a platform rather than a single dispensary or grow.
Its current public footprint should be assessed brand by brand. The 2019 portfolio is historically important, while current company materials and live retailer data are needed to determine which labels, facilities and channels remain active now.
How to evaluate the company today. Consumers should verify the brand and legal producer printed on a package, the license number, testing label, batch date and retailer license. Investors or partners should separately confirm corporate ownership, active premises and current management instead of relying on an old press release.
The durable facts are the 2014 formation, Patel and Cortina’s co-founding roles, the buildout across San Francisco and Santa Rosa, the 2018 state-market transition and the 2019 house-of-brands strategy. Current scale claims deserve a date and source every time.